Anti-Obesity Drugs Market Analysis to 2027 - Arena Pharmaceuticals, GlaxoSmithKline, Alizyme, Boehringer Ingelheim, Novo Nordisk, Pfizer, Shionogi, Merck, and Norgine
Pharmacological agents which are used to reduce the body weight by losing the amount of cholesterol in body are called as Anti-obesity drugs. Anti-Obesity drugs alter the fundamental functions of human body by altering the appetite or by consuming the calories.
Download PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPRE00006850/
The report analyzes factors affecting Anti-Obesity Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Obesity Drugs market in these regions.
Top Dominating Industry Players:
1. Arena Pharmaceuticals, Inc.
2. F. Hoffmann-La Roche Ltd
3. GlaxoSmithKline plc
4. Alizyme plc
5. Boehringer Ingelheim GmbH
6. Novo Nordisk A/S
7. Pfizer Inc
8. Shionogi Inc.
9. Merck and Co., Inc.
10. Norgine B.V.
The global Anti-Obesity Drugs market is segmented on the basis of drug class, medication, and drug type. Based on drug class, the market is segmented into Peripherally Acting Anti-obesity Drugs, and Centrally Acting Anti-obesity Drugs. Based on medication, the market is segmented into Monotherapies and Polytherapies. Based on drug type, the market is segmented into Prescription Drugs and OTC Drugs.
Access the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPRE00006850/
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anti-Obesity Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-Obesity Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Obesity Drugs Market Analysis to 2027 - Arena Pharmaceuticals, GlaxoSmithKline, Alizyme, Boehringer Ingelheim, Novo Nordisk, Pfizer, Shionogi, Merck, and Norgine here
News-ID: 1851424 • Views: 134
More Releases from The Insight Partners
Trade Finance Market – Detailed Analysis of Current Industry Figures with Fore …
The report presents the current market analysis scenario, future and future opportunities, revenue growth, prices and profitability. The proprietary data in this report is collected by Insight Partner’s dedicated research and analysis team of experienced professionals with advanced statistical expertise and various customization options in the existing study. Trade finance is a type of commercial activity that is closely associated with the story of human trade evolution. In trade businesses it
Lab Automation Industry Analysis by Top Players as Tecan Trading AG,, PerkinElme …
Lab Automation or Laboratory automation is a multi-disciplinary strategy to develop, research and optimize technologies in the clinical laboratory. Request a Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001249/?utm_source=OpenPR&utm_medium=Sumaiya The application of this technology in laboratories helps to achieve higher levels of performance in less time. Laboratory automation aids increasing productivity, reducing lab process cycle times, elevating experimental data quality and enabling easy experimentation. Moreover, the system includes development of the laboratory information (management) systems (LIS/LIMS)
Industrial Agitator Market SWOT Analysis and Segments from 2019-2027 | Xylem, SP …
According to the new research report published by The Insight Partners, titled “Industrial Agitator Market - Global Analysis and Forecast to 2027”, the global industrial agitator market is expected to reach US$ 4.65 Bn in 2027, registering a CAGR of 7.8% during the forecast period 2019-2027. Manufacturers from several industries are now a days highly focused on achieving new growth mark. Chemical industry is major revenue contributor to this market with
Security Screening Market Size, Share, Growth Analysis and Forecasts 2029-2027 | …
The global air travel industry is growing at a rapid pace. The factors such as high living standards coupled with rising middle class population particularly, in emerging markets has resulted in the increased growth. The global economic conditions as well as lower airfares are the major reason contributing to the growth. Also, progress in consumer spending related to tourism and travel in key economies has strengthened the demand for air
More Releases for Drugs
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of